Skip to content

Apogee Therapeutics, Inc. APGE Prepaid & Other Current

Prepaid & Other Current at other companies

Eli Lilly logo
Eli LillyLLY
$13.63B-7.0%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$620.9M+32.4%
AbbVie logo
AbbVieABBV
$150M-97.3%
Summit Therapeutics logo
Summit TherapeuticsSMMT
$17.55M+92.5%
Immunovant, Inc. logo
Immunovant, Inc.IMVT
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX

Other financials

Income statement

See full
Operating income-$82.8M-31.2%
Net income-$74.1M-33.9%
EPS (diluted)-$1.06-11.6%

Balance sheet

See full
Cash & equivalents$451.8M+323%
Total debt$8.0M-31.9%
Total assets$1.3B+81.1%

Cash flow

See full
Operating cash flow-$55.6M-14.6%
CapEx$62.0K
Free cash flow-$62.8M+7.3%

Valuation

See full
Market cap$6.81B+189%
Enterprise value$6.37B+181%

Returns & leverage

See full
Current ratio32.6×+16.8×

Where this comes from

Reported directly by Apogee Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:PrepaidExpenseAndOtherAssetsCurrent.

The official record: Apogee Therapeutics, Inc.’s 10-Q, filed May 11, 2026, on SEC EDGAR. View the filing →

Ask your AI about Apogee Therapeutics, Inc.'s prepaid & other current.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Apogee Therapeutics, Inc.'s prepaid & other current?
Apogee Therapeutics, Inc. (APGE) reported prepaid & other current of $13.91M in Q1 2026.
How has Apogee Therapeutics, Inc.'s prepaid & other current changed year-over-year?
Apogee Therapeutics, Inc.'s prepaid & other current increased by 69.6% year-over-year, from $8.2M to $13.91M.
What is the long-term trend for Apogee Therapeutics, Inc.'s prepaid & other current?
Over 3 years (2022 to 2025), Apogee Therapeutics, Inc.'s prepaid & other current has grown at a 307.5% compound annual growth rate (CAGR), from $165K to $11.17M.
What does prepaid & other current mean?
Advance payments for expenses (rent, insurance, subscriptions) plus miscellaneous current assets not classified elsewhere.